ERFE’s role as the principal erythroid regulator of iron homeostasis due to its effect on the hepcidin/ferroportin axis in humans is already well studied, just as its pathological role in anemias with ineffective erythropoiesis, for example in thalassemia intermedia, which was demonstrated in in-vivo models. This evidence concerns the gene HAMP and anemia (phenotype).